Evidence for DNA Damage as a Biological Link Between Diabetes and Cancer

Objective:This review examines the evidence that: Diabetes is a state of DNA damage; pathophysiological factors in diabetes can cause DNA damage; DNA damage can cause mutations; and DNA mutation is linked to carcinogenesis. Data Sources:We retrieved information from the PubMed database up to January, 2014, using various search terms and their combinations including DNA damage, diabetes, cancer, high glucose, hyperglycemia, free fatty acids, palmitic acid, advanced glycation end products, mutation and carcinogenesis. Study Selection:We included data from peer-reviewed journals and a textbook printed in English on relationships between DNA damage and diabetes as well as pathophysiological factors in diabetes. Publications on relationships among DNA damage, mutagenesis, and carcinogenesis, were also reviewed. We organized this information into a conceptual framework to explain the possible causal relationship between DNA damage and carcinogenesis in diabetes. Results:There are a large amount of data supporting the view that DNA mutation is a typical feature in carcinogenesis. Patients with type 2 diabetes have increased production of reactive oxygen species, reduced levels of antioxidant capacity, and increased levels of DNA damage. The pathophysiological factors and metabolic milieu in diabetes can cause DNA damage such as DNA strand break and base modification (i.e., oxidation). Emerging experimental data suggest that signal pathways (i.e., Akt/tuberin) link diabetes to DNA damage. This collective evidence indicates that diabetes is a pathophysiological state of oxidative stress and DNA damage which can lead to various types of mutation to cause aberration in cells and thereby increased cancer risk. Conclusions:This review highlights the interrelationships amongst diabetes, DNA damage, DNA mutation and carcinogenesis, which suggests that DNA damage can be a biological link between diabetes and cancer.

[1]  Jie Du,et al.  Potential role of Akt signaling in chronic kidney disease. , 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[2]  D. Adams,et al.  Mutation, clonal fitness and field change in epithelial carcinogenesis , 2014, The Journal of pathology.

[3]  K. Gundogan,et al.  Evaluation of chromosomal damage, cytostasis, cytotoxicity, oxidative DNA damage and their association with body-mass index in obese subjects. , 2014, Mutation research. Genetic toxicology and environmental mutagenesis.

[4]  R. Ozaki,et al.  Additive effects of blood glucose lowering drugs, statins and renin-angiotensin system blockers on all-site cancer risk in patients with type 2 diabetes , 2014, BMC Medicine.

[5]  E. Schleicher,et al.  Effect of metformin on methylglyoxal metabolism in patients with type 2 diabetes. , 2014, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[6]  S. Liang,et al.  Hyperactivation of Akt/mTOR and deficiency in tuberin increased the oxidative DNA damage in kidney cancer patients with diabetes , 2014, Oncotarget.

[7]  M. Ng,et al.  Genetic variants for type 2 diabetes and new-onset cancer in Chinese with type 2 diabetes. , 2014, Diabetes research and clinical practice.

[8]  Carlos Sonnenschein,et al.  One hundred years of somatic mutation theory of carcinogenesis: Is it time to switch? , 2014, BioEssays : news and reviews in molecular, cellular and developmental biology.

[9]  Joung-Sun Park,et al.  Mechanism of metformin: Inhibition of DNA damage and proliferative activity in Drosophila midgut stem cell , 2013, Mechanisms of Ageing and Development.

[10]  K. Asanuma,et al.  Telmisartan inhibits AGE-induced podocyte damage and detachment. , 2013, Microvascular research.

[11]  H. Stopper,et al.  Insulin mediated DNA damage in mammalian colon cells and human lymphocytes in vitro. , 2013, Mutation research.

[12]  Y. Bao,et al.  Cancer Incidence and Mortality in Patients with Type 2 Diabetes Treated with Human Insulin: A Cohort Study in Shanghai , 2013, PloS one.

[13]  Cynthia J. Sakofsky,et al.  Break-Induced Replication and Genome Stability , 2012, Biomolecules.

[14]  Xilin Yang,et al.  Diabetes and cancer: the mechanistic implications of epidemiological analyses from the Hong Kong Diabetes Registry , 2012, Diabetes/metabolism research and reviews.

[15]  N. R. Jena DNA damage by reactive species: Mechanisms, mutation and repair , 2012, Journal of Biosciences.

[16]  H. G. van der Poel,et al.  Akt-mediated phosphorylation of Bmi1 modulates its oncogenic potential, E3 ligase activity, and DNA damage repair activity in mouse prostate cancer. , 2012, The Journal of clinical investigation.

[17]  J. Burgess,et al.  Differential effects of α-tocopherol and N-acetyl-cysteine on advanced glycation end product-induced oxidative damage and neurite degeneration in SH-SY5Y cells. , 2012, Biochimica et biophysica acta.

[18]  G. Bochi,et al.  Association between DNA strand breakage and oxidative, inflammatory and endothelial biomarkers in type 2 diabetes. , 2012, Mutation research.

[19]  Yuanzhi Lao,et al.  Akt: A Double-Edged Sword in Cell Proliferation and Genome Stability , 2012, Journal of oncology.

[20]  A. Vikram,et al.  Alkaline, Endo III and FPG modified comet assay as biomarkers for the detection of oxidative DNA damage in rats with experimentally induced diabetes. , 2011, Mutation research.

[21]  Xin Gao,et al.  Diabetes causes multiple genetic alterations and downregulates expression of DNA repair genes in the prostate , 2011, Laboratory Investigation.

[22]  Pingsheng Liu,et al.  Palmitic acid acutely stimulates glucose uptake via activation of Akt and ERK1/2 in skeletal muscle cells[S] , 2011, Journal of Lipid Research.

[23]  H. Jelinek,et al.  Oxidative DNA damage and obesity in type 2 diabetes mellitus. , 2011, European journal of endocrinology.

[24]  Toru Kagawa,et al.  Possible involvement of intracellular angiotensin II receptor in high-glucose-induced damage in renal proximal tubular cells. , 2011, Journal of nephrology.

[25]  Mark I McCarthy,et al.  Genomics, type 2 diabetes, and obesity. , 2010, The New England journal of medicine.

[26]  Edward Giovannucci,et al.  Diabetes and Cancer , 2010, Diabetes Care.

[27]  M. Goodarzi,et al.  Oxidative damage to DNA and lipids: correlation with protein glycation in patients with type 1 diabetes , 2010, Journal of clinical laboratory analysis.

[28]  Xilin Yang,et al.  Associations of Hyperglycemia and Insulin Usage With the Risk of Cancer in Type 2 Diabetes: The Hong Kong Diabetes Registry , 2010, Diabetes.

[29]  James E. Klaunig,et al.  Oxidative Stress and Oxidative Damage in Carcinogenesis , 2010, Toxicologic pathology.

[30]  S. Habib,et al.  Molecular mechanism of regulation of OGG 1 : tuberin deficiency results in cytoplasmic redistribution of transcriptional factor , 2010 .

[31]  Weiping Jia,et al.  Diabetes in Asia: epidemiology, risk factors, and pathophysiology. , 2009, JAMA.

[32]  H. Abboud,et al.  Mechanism of Oxidative DNA Damage in Diabetes , 2008, Diabetes.

[33]  J. Błasiak,et al.  In vitro effect of gliclazide on DNA damage and repair in patients with type 2 diabetes mellitus (T2DM). , 2008, Chemico-biological interactions.

[34]  Xilin Yang,et al.  Predicting values of lipids and white blood cell count for all-site cancer in type 2 diabetes. , 2008, Endocrine-related cancer.

[35]  X. Adiconis,et al.  PPARGC1A Variation Associated With DNA Damage, Diabetes, and Cardiovascular Diseases , 2008, Diabetes.

[36]  Xilin Yang,et al.  Development and validation of an all-cause mortality risk score in type 2 diabetes. , 2008, Archives of internal medicine.

[37]  Ying Zhang,et al.  High level glucose increases mutagenesis in human lymphoblastoid cells , 2007, International journal of biological sciences.

[38]  Shuo Yang,et al.  Activated IGF-1R inhibits hyperglycemia-induced DNA damage and promotes DNA repair by homologous recombination. , 2005, American journal of physiology. Renal physiology.

[39]  A. Heidland,et al.  Genotoxicity of Advanced Glycation End Products: Involvement of Oxidative Stress and of Angiotensin II Type 1 Receptors , 2005, Annals of the New York Academy of Sciences.

[40]  Janusz Blasiak,et al.  DNA damage and repair in type 2 diabetes mellitus. , 2004, Mutation research.

[41]  Antonio Ceriello,et al.  Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation. , 2003, Diabetes.

[42]  J. Chambers,et al.  Linoleic acid and antioxidants protect against DNA damage and apoptosis induced by palmitic acid. , 2003, Mutation research.

[43]  M. Evans,et al.  Oxidative DNA damage: mechanisms, mutation, and disease , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[44]  H. İlkova,et al.  DNA damage and antioxidant defense in peripheral leukocytes of patients with Type I diabetes mellitus. , 2003, Mutation research.

[45]  Donghui Li,et al.  Reduced constitutive 8-oxoguanine-DNA glycosylase expression and impaired induction following oxidative DNA damage in the tuberin deficient Eker rat. , 2003, Carcinogenesis.

[46]  A. Heidland,et al.  Genotoxicity of advanced glycation end products in mammalian cells. , 2003, Cancer letters.

[47]  S. Nicosia,et al.  Phosphatidylinositol 3-Kinase/Akt Pathway Regulates Tuberous Sclerosis Tumor Suppressor Complex by Phosphorylation of Tuberin* , 2002, The Journal of Biological Chemistry.

[48]  J. Drai,et al.  Oxidative stress parameters in type I, type II and insulin-treated type 2 diabetes mellitus; insulin treatment efficiency. , 2002, Clinica chimica acta; international journal of clinical chemistry.

[49]  A. Peiris,et al.  Insulin: a novel factor in carcinogenesis. , 2002, The American journal of the medical sciences.

[50]  Y. Yamori,et al.  Phytoestrogens attenuate oxidative DNA damage in vascular smooth muscle cells from stroke‐prone spontaneously hypertensive rats , 2000, Journal of hypertension.

[51]  D. Livingston,et al.  In search of the tumour-suppressor functions of BRCA1 and BRCA2 , 2000, Nature.

[52]  W. Zidek,et al.  Reactive oxygen species in essential hypertension and non-insulin-dependent diabetes mellitus. , 1999, American journal of hypertension.

[53]  Y. Hinokio,et al.  Oxidative DNA damage in diabetes mellitus: its association with diabetic complications , 1999, Diabetologia.

[54]  U. Eriksson,et al.  Hyperglycemia-induced embryonic dysmorphogenesis correlates with genomic DNA mutation frequency in vitro and in vivo. , 1999, Diabetes.

[55]  A. Collins,et al.  DNA damage in diabetes: correlation with a clinical marker. , 1998, Free radical biology & medicine.

[56]  T. Nicotera,et al.  Oxidative damage to DNA in diabetes mellitus , 1996, The Lancet.

[57]  H. Joenje,et al.  Mutational specificity of oxidative DNA damage. , 1993, Mutation research.

[58]  L. Berstein,et al.  Glucose consumption, newborn weight and nitrosomethylurea transplacental carcinogenesis in rats. , 1984, Cancer letters.

[59]  M. Fox Fundamentals of Oncology , 1979, British Journal of Cancer.

[60]  C. Riggs,et al.  Effects of glucose on cloning efficiency and mutagenesis of fetal rat cells. , 2002, Teratogenesis, carcinogenesis, and mutagenesis.

[61]  Mara,et al.  High glucose induces DNA damage in cultured human endothelial cells. , 1986, The Journal of clinical investigation.